AIIMS Delhi to start human trials of COVID-19 vaccine Covaxin from Monday
The AIIMS Ethics Committee has approved human clinical trials of the indigenously developed COVID-19 vaccine candidate Covaxin.
Full Article
AIIMS Delhi to start human trials of COVID-19 vaccine Covaxin from Monday
DNA
0 shares
1 views
You might like
Related news coverage
India readies five sites for final phase of human trials of Oxford COVID vaccine
Mid-Day
New Delhi: Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19..
-
Phase-I human clinical trial of potential Covid-19 vaccine: Man given first dose at AIIMS
IndiaTimes
-
Delhi: 1,800 call to volunteer for Covid-19 vaccine trial at AIIMS, only 100 required
IndiaTimes
-
AIIMS director on Covid vaccine human trials, community spread: Key points
IndiaTimes
-
AIIMS director on human trials: Key points
IndiaTimes
Advertisement
More coverage
India records highest single-day spike of over 22K COVID-19 cases
Mid-Day
India on Saturday recorded the highest single-day spike of 22,771 cases, pushing the total tally to 6,48,315, the Ministry of..